These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23072134)
21. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping. Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351 [TBL] [Abstract][Full Text] [Related]
22. [Recurrent Plasmodium vivax malaria in spite of primaquine follow-up treatment]. Telgt DS; Mulder L; Dolmans WM Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1783-6. PubMed ID: 9545728 [TBL] [Abstract][Full Text] [Related]
23. [The treatment of malaria]. Kager PA; Zijlmans CW; Boele van Hensbroek M; Wetsteyn JC Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1774-8. PubMed ID: 9545726 [TBL] [Abstract][Full Text] [Related]
24. Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors. Gomes Mdo S; Vieira JL; Machado RL; Nacher M; Stefani A; Musset L; Legrand E; Menezes RA; Júnior AA; Sousa AP; Couto VS; Couto ÁA Malar J; 2015 Oct; 14():402. PubMed ID: 26453152 [TBL] [Abstract][Full Text] [Related]
26. Chloroquine sensitivity of Plasmodium vivax in Thailand. Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823 [TBL] [Abstract][Full Text] [Related]
27. Relapses of vivax malaria after a conventional course of primaquine and chloroquine: report of 2 cases. Charoenlarp P; Harinasuta T Southeast Asian J Trop Med Public Health; 1973 Mar; 4(1):135-7. PubMed ID: 4577922 [No Abstract] [Full Text] [Related]
28. Toxicity related to chloroquine treatment of resistant vivax malaria. Davis TM; Syed DA; Ilett KF; Barrett PH Ann Pharmacother; 2003 Apr; 37(4):526-9. PubMed ID: 12659609 [TBL] [Abstract][Full Text] [Related]
29. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine. Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694 [TBL] [Abstract][Full Text] [Related]
30. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report. Kristensen KL; Dragsted UB Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539 [TBL] [Abstract][Full Text] [Related]
31. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax]. Nicolas X; Granier H; Martin J; Klotz F Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600 [TBL] [Abstract][Full Text] [Related]
32. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand. Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544 [TBL] [Abstract][Full Text] [Related]
34. Plasmodium vivax malaria presenting with skin rash--a case report. Zaki SA; Shanbag P J Vector Borne Dis; 2011 Dec; 48(4):245-6. PubMed ID: 22297289 [No Abstract] [Full Text] [Related]
35. Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border. Maneeboonyang W; Lawpoolsri S; Puangsa-Art S; Yimsamran S; Thanyavanich N; Wuthisen P; Prommongkol S; Chaimongkul W; Rukmanee P; Rukmanee N; Chavez IF; Buchachart K; Krudsood S; Singhasivanon P Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):9-18. PubMed ID: 21323159 [TBL] [Abstract][Full Text] [Related]
36. Treatment of Plasmodium vivax malaria--time for a change? Doherty JF; Day JH; Warhurst DC; Chiodini PL Trans R Soc Trop Med Hyg; 1997; 91(1):76. PubMed ID: 9093635 [No Abstract] [Full Text] [Related]
37. [Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004]. Carmona-Fonseca J; Alvarez G Biomedica; 2006 Sep; 26(3):353-65. PubMed ID: 17175999 [TBL] [Abstract][Full Text] [Related]
38. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010. Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279 [TBL] [Abstract][Full Text] [Related]
39. A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax. Gogtay N; Garg M; Kadam V; Kamtekar K; Kshirsagar NA Trans R Soc Trop Med Hyg; 1998; 92(3):341. PubMed ID: 9861412 [No Abstract] [Full Text] [Related]